bivalent VesiculoVax-vectored Chikungunya virus vaccine (Auro vaccines)

N/A

Report date: 2025/03/14 16:42:52

Base Information

Drug Namebivalent VesiculoVax-vectored Chikungunya virus vaccine (Auro vaccines)
Drug Alias Namebivalent VesiculoVax-vectored Chikungunya/Zika virus vaccine (Profectus Biosciences)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsZika Virus InfectionChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAuro Vaccines Llc
Inactive Companies +[1]  N/A
Active IndicationsChikungunya Fever
Inactive IndicationsZika Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A